Richard J. Popert, MD

Guy's & St Thomas' Nhs Trust

Rick Popert Consultant Urologist Guy's Hospital London.
Dr Popert's clinical expertise is in the comprehensive evalulation and surgical treatment of benign and malignant prostatic disease.
His surgical expertise is in:
ROBOTIC RADICAL PROSTATECTOMY
DYNAMIC PROSTATE BRACHYTHERAPY
HOLMIUM LASER PROSTATECTOMY
PRECISION PROSTATE DIAGNOSTICS - TRANSPERINEAL AND MRI – FUSION BIOPSIES
PROSTATE ARTERIAL EMBOLISATION
He has successfully transferred his experience from conventional open radical prostatectomy to the robotic assisted approach. He has carried out over 1200 robotic prostatectomies since 2006. 
He has the UK's largest experience of single visit dynamic intra-operative prostate brachytherapy and has carried out over 1000 of these cases since 2004.
He is an expert in Precision Prostate Diagnostics and has developed a rapid access prostate MRI assessment service along with a unique systematic transperineal biopsy approach which provides accurate tumour localisation, an approach that has been further enhanced by the technique of MRI fusion targeted biopsy of the prostate which he introduced in March 2012. 
Over the last two years he has transformed transperineal prostate biopsy practice with the introduction of local anaesthetic transperineal biopsies. He has been appointed as a Fellow to the NHS Innovation Accelerator Programme with a remit to roll out LA TP biopies across the UK 
For benign prostatic disease, he has one of the UK's largest experience of holmium laser prostatectomy (HoLEP). Since 2003 he has carried out over 1200 holmium laser enucleations with reduced bleeding and length of stay in patients with prostate volumes larger than 100 cc compared with standard transurethral prostatectomy (TURP).
In 2014 he introduced a prostate arterial embolisation service in association with the Interventional Radiology Team at Guy’s Hospital. This is a minimally invasive out patient procedure which is alternative to the surgical management of benign prostatic disease, avoiding the complications of urinary incontinence, erectile and ejaculatory dysfunction.

Disclosure information not submitted.

Presentation(s):

• Session I: Early Disease

  Sunday, May 15, 2022
  8:05 AM – 9:15 AM

• Panel Discussion: Challenging Cases in Prostate Cancer Screening

  Sunday, May 15, 2022
  8:45 AM – 9:15 AM